Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 2;11(11):3165.
doi: 10.3390/jcm11113165.

Risk Factors and Outcomes of Acute Graft Pyelonephritis with Bacteremia Due to Multidrug-Resistant Gram-Negative Bacilli among Kidney Transplant Recipients

Affiliations

Risk Factors and Outcomes of Acute Graft Pyelonephritis with Bacteremia Due to Multidrug-Resistant Gram-Negative Bacilli among Kidney Transplant Recipients

Núria Sabé et al. J Clin Med. .

Abstract

Acute graft pyelonephritis (AGP) is the leading cause of bloodstream infection in kidney transplant (KT) recipients. The prevalence of urinary tract infections caused by multidrug-resistant (MDR) Gram-negative bacilli is increasing. This 14-year prospective observational study sought to determine the clinical characteristics, risk factors, and outcomes of AGP with bacteremia due to MDR Gram-negative bacilli. Overall, 278 episodes of AGP with bacteremia due to MDR Gram-negative and non-MDR Gram-negative bacilli were identified and compared in 214 KT recipients; MDR Gram-negative bacilli were the cause in 28.4%. Overall 30-day mortality was low (1.1%). Risk factors independently associated with AGP due to MDR Gram-negative bacilli were male sex (OR 3.08; 95%CI 1.60-5.93), previous episode of bacteremic AGP (OR 2.11, 95%CI 1.09-4.09), prior antibiotic therapy in the preceding month (OR 2.47, 95%CI 1.33-4.57), and nosocomial acquisition (OR 2.03, 95%CI 1.14-3.62). Forty-three percent of MDR Gram-negative episodes received inappropriate empirical antibiotic therapy. The risk factors identified in this study may help physicians when selecting empirical antibiotic treatment for AGP. Previous antibiotic use was the main modifiable factor. Its presence highlights the importance of avoiding unnecessary antibiotics in order to bring down the high rates of MDR Gram-negative bacilli infections in this population.

Keywords: acute graft pyelonephritis; bacteremia; bloodstream infection; kidney transplant; multidrug-resistant.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

Cited by

References

    1. Kritikos A., Manuel O. Bloodstream infections after solid-organ transplantation. Virulence. 2016;7:329–340. doi: 10.1080/21505594.2016.1139279. - DOI - PMC - PubMed
    1. Pouch S.M., Patel G., AST Infectious Diseases Community of Practice Multidrug-resistant Gram-negative bacterial infections in solid organ transplant recipients-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin. Transpl. 2019;33:e13594. doi: 10.1111/ctr.13594. - DOI - PubMed
    1. Cervera C., van Delden C., Gavaldà J., Welte T., Akova M., Carratalà J., ESCMID Study Group for Infections in Compromised Hosts Multidrug-resistant bacteria in solid organ transplant recipients. Clin. Microbiol. Infect. 2014;20:49–73. doi: 10.1111/1469-0691.12687. - DOI - PubMed
    1. Parasuraman R., Julian K., AST Infectious Diseases Community of Practice Urinary tract infections in solid organ transplantation. Am. J. Transpl. 2013;13:327–336. doi: 10.1111/ajt.12124. - DOI - PubMed
    1. Vidal E., Torre-Cisneros J., Blanes M., Montejo M., Cervera C., Aguado J.M., Len O., Carratalá J., Cordero E., Bou G., et al. Bacterial urinary tract infection after solid organ transplantation in the RESITRA cohort. Transpl. Infect. Dis. 2012;14:595–603. doi: 10.1111/j.1399-3062.2012.00744.x. - DOI - PubMed